We are live on ! Find out more
AGIO icon

Agios Pharmaceuticals
AGIO

167 hedge funds and large institutions have $2.37B invested in Agios Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 84 increasing their positions, 34 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

147% more repeat investments, than reductions

Existing positions increased: 84 | Existing positions reduced: 34

75% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 16

7% more funds holding

Funds holding: 156 → 167 (+11)

1% less capital invested

Capital invested by funds: $2.39B → $2.37B (-$19.4M)

1.34% less ownership

Funds ownership: 97.02% → 95.68% (-1.3%)

38% less call options, than puts

Call options by funds: $11.1M | Put options by funds: $17.9M

43% less funds holding in top 10

Funds holding in top 10: 7 → 4 (-3)

Holders
167
Holders Change
+11
Holders Change %
+7.05%
% of All Funds
4.16%
Holding in Top 10
4
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-42.86%
% of All Funds
0.1%
New
28
Increased
84
Reduced
34
Closed
16
Calls
$11.1M
Puts
$17.9M
Net Calls
-$6.77M
Net Calls Change
-$3.2M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$45.8M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$43.7M
3
Invesco
Invesco
Georgia
+$34.3M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$31.6M
5
BlackRock
BlackRock
New York
+$26M

Top Sellers

1
FP
Flagship Pioneering
Massachusetts
-$56.4M
2
RG
Redmile Group
California
-$11.3M
3
CGT
Capital Guardian Trust
California
-$7.88M
4
GTC
Ghost Tree Capital
New York
-$7.3M
5
Capital Fund Management (CFM)
Capital Fund Management (CFM)
France
-$5.15M
Name Holding Trade Value Shares
Change 		Change in
Stake
SIM
51
Spark Investment Management
New York
$4.36M +$2.53M +49,400 +140%
Morgan Stanley
52
Morgan Stanley
New York
$3.92M +$605K +11,840 +18%
California State Teachers Retirement System (CalSTRS)
53
California State Teachers Retirement System (CalSTRS)
California
$3.82M +$650K +12,716 +21%
Swiss National Bank
54
Swiss National Bank
Switzerland
$3.41M +$557K +10,900 +20%
GC
55
Guggenheim Capital
Illinois
$3.21M +$372K +7,270 +13%
CII
56
Capital International Inc
California
$3.17M -$1.23M -24,100 -28%
JGC
57
J. Goldman & Co
New York
$3.02M +$3.01M +58,800 New
Barclays
58
Barclays
United Kingdom
$2.99M -$1.08M -21,176 -27%
HLA
59
Hamilton Lane Advisors
Pennsylvania
$2.89M +$2.87M +56,170 New
EVM
60
Eaton Vance Management
Massachusetts
$2.82M – – –
TRSOTSOK
61
Teachers Retirement System of the State of Kentucky
Kentucky
$2.62M +$421K +8,233 +19%
State Board of Administration of Florida Retirement System
62
State Board of Administration of Florida Retirement System
Florida
$2.6M +$570K +11,156 +28%
Ameriprise
63
Ameriprise
Minnesota
$2.57M +$458K +8,965 +22%
Asset Management One
64
Asset Management One
Japan
$2.52M +$271K +5,308 +12%
Fiera Capital (Canada)
65
Fiera Capital (Canada)
Quebec, Canada
$2.51M -$294K -5,741 -11%
Canada Pension Plan Investment Board
66
Canada Pension Plan Investment Board
Ontario, Canada
$2.48M +$900K +17,600 +58%
TA
67
Teachers Advisors
New York
$2.4M +$842K +16,475 +54%
QIM
68
Quantitative Investment Management
Virginia
$2.39M -$1.26M -24,600 -35%
RhumbLine Advisers
69
RhumbLine Advisers
Massachusetts
$2.38M +$479K +9,374 +25%
BG
70
Bellevue Group
Switzerland
$2.31M – – –
AA
71
ALPS Advisors
Colorado
$2.24M +$367K +7,176 +20%
Two Sigma Advisers
72
Two Sigma Advisers
New York
$2.18M +$266K +5,200 +14%
UBS Group
73
UBS Group
Switzerland
$1.98M +$1.74M +34,112 +791%
IBT
74
International Biotechnology Trust
United Kingdom
$1.9M +$869K +17,000 +85%
PIM
75
Platinum Investment Management
Australia
$1.84M – – –
1 2
3
4 5

AGIO Hedge Fund Activity: Q2 2017 in Review

167 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Agios Pharmaceuticals (AGIO) for Q2 2017, worth a combined $2.37B — down 0.81% from $2.39B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new AGIO positions and 16 closed out — a net gain of 12 holders — while 84 added to existing stakes and 34 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $45.8M. The largest seller was Flagship Pioneering, exiting entirely with an estimated $56.4M sold.

  • 167 institutional investors held Agios Pharmaceuticals (AGIO) as of Q2 2017, up from 156 in Q1 2017.
  • Funds reported $2.37B of Agios Pharmaceuticals stock for Q2 2017, down 0.81% quarter-over-quarter.
  • 28 funds opened new Agios Pharmaceuticals positions in Q2 2017 and 16 closed out, a net change of +12 holders.
  • The largest Agios Pharmaceuticals buyer in Q2 2017 was Fidelity Investments, an estimated $45.8M added.
  • The largest Agios Pharmaceuticals seller in Q2 2017 was Flagship Pioneering, an estimated $56.4M sold.

Based on aggregated 13F filings for Q2 2017.